These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Design, synthesis and biological evaluation of 7-methylimidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD4 inhibitors. Zhao L; Yang Y; Guo Y; Yang L; Zhang J; Zhou J; Zhang H Bioorg Med Chem; 2017 Apr; 25(8):2482-2490. PubMed ID: 28314513 [TBL] [Abstract][Full Text] [Related]
26. An Overview on Small Molecule Inhibitors of BRD4. Huang W; Zheng X; Yang Y; Wang X; Shen Z Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915 [TBL] [Abstract][Full Text] [Related]
27. Structural variation of protein-ligand complexes of the first bromodomain of BRD4. Guest EE; Pickett SD; Hirst JD Org Biomol Chem; 2021 Jun; 19(25):5632-5641. PubMed ID: 34105560 [TBL] [Abstract][Full Text] [Related]
28. Importance of a crystalline water network in docking-based virtual screening: a case study of BRD4. Zhong H; Wang Z; Wang X; Liu H; Li D; Liu H; Yao X; Hou T Phys Chem Chem Phys; 2019 Dec; 21(45):25276-25289. PubMed ID: 31701109 [TBL] [Abstract][Full Text] [Related]
29. Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4. Allen BK; Mehta S; Ember SW; Schonbrunn E; Ayad N; Schürer SC Sci Rep; 2015 Nov; 5():16924. PubMed ID: 26596901 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research. Yoo M; Park TH; Yoo M; Kim Y; Lee JY; Lee KM; Ryu SE; Lee BI; Jung KY; Park CH Molecules; 2021 Mar; 26(6):. PubMed ID: 33802888 [TBL] [Abstract][Full Text] [Related]
31. Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain. Lolli G; Battistutta R Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):2161-4. PubMed ID: 24100334 [TBL] [Abstract][Full Text] [Related]
32. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. Liu Z; Li Y; Chen H; Lai HT; Wang P; Wu SY; Wold EA; Leonard PG; Joseph S; Hu H; Chiang CM; Brasier AR; Tian B; Zhou J J Med Chem; 2022 Feb; 65(3):2388-2408. PubMed ID: 34982556 [TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of BET bromodomains. Filippakopoulos P; Qi J; Picaud S; Shen Y; Smith WB; Fedorov O; Morse EM; Keates T; Hickman TT; Felletar I; Philpott M; Munro S; McKeown MR; Wang Y; Christie AL; West N; Cameron MJ; Schwartz B; Heightman TD; La Thangue N; French CA; Wiest O; Kung AL; Knapp S; Bradner JE Nature; 2010 Dec; 468(7327):1067-73. PubMed ID: 20871596 [TBL] [Abstract][Full Text] [Related]
34. Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors. Noguchi-Yachide T; Sakai T; Hashimoto Y; Yamaguchi T Bioorg Med Chem; 2015 Mar; 23(5):953-9. PubMed ID: 25678016 [TBL] [Abstract][Full Text] [Related]
35. RVX-297- a novel BD2 selective inhibitor of BET bromodomains. Kharenko OA; Gesner EM; Patel RG; Norek K; White A; Fontano E; Suto RK; Young PR; McLure KG; Hansen HC Biochem Biophys Res Commun; 2016 Aug; 477(1):62-67. PubMed ID: 27282480 [TBL] [Abstract][Full Text] [Related]
36. Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4. Schulze J; Moosmayer D; Weiske J; Fernández-Montalván A; Herbst C; Jung M; Haendler B; Bader B J Biomol Screen; 2015 Feb; 20(2):180-9. PubMed ID: 25266565 [TBL] [Abstract][Full Text] [Related]
38. Disrupting Acetyl-lysine Interactions: Recent Advance in the Development of BET Inhibitors. Zhang F; Ma S Curr Drug Targets; 2018; 19(10):1148-1165. PubMed ID: 29189147 [TBL] [Abstract][Full Text] [Related]
39. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen. Ayoub AM; Hawk LML; Herzig RJ; Jiang J; Wisniewski AJ; Gee CT; Zhao P; Zhu JY; Berndt N; Offei-Addo NK; Scott TG; Qi J; Bradner JE; Ward TR; Schönbrunn E; Georg GI; Pomerantz WCK J Med Chem; 2017 Jun; 60(12):4805-4817. PubMed ID: 28535045 [TBL] [Abstract][Full Text] [Related]
40. Discovery of novel BET inhibitors by drug repurposing of nitroxoline and its analogues. Jiang H; Xing J; Wang C; Zhang H; Yue L; Wan X; Chen W; Ding H; Xie Y; Tao H; Chen Z; Jiang H; Chen K; Chen S; Zheng M; Zhang Y; Luo C Org Biomol Chem; 2017 Nov; 15(44):9352-9361. PubMed ID: 29087414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]